In vivo performance of wax matrix granules prepared by a twin-screw compounding extruder

被引:12
作者
Miyagawa, Y
Sato, H
Okabe, T
Nishiyama, T
Miyajima, M
Sunada, H
机构
[1] Zeria Pharmaceut Co Ltd, Cent Res Labs, Konan 3600111, Japan
[2] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 468, Japan
关键词
D O I
10.1081/DDC-100102192
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The in vivo performance of wax matrix granules (WMGs) prepared by a twin-screw compounding extruder was evaluated in fasted beagle dogs. in vitro dissolution behavior of the model drug, diclofenac sodium (DS), from WMGs was strongly influenced by pH in a dissolution medium due to its solubility (DS is soluble in pH 6.8 and insoluble in pH 1.2 and 4.0) and was independent of paddle rotation rate (50, 100, and 200 rpm) of the dissolution apparatus. Pharmacokinetics parameters such as mean residence time (MRT) showed a sustained action of WMGs in beagle dogs; however the transit time of WMGs in the small intestine is found to control total drug absorption. Furthermore, the values of the area under the curve (AUC) of the plasma concentration-time curve and the maximum concentration C-max significantly decreased with decreases in hydroxypropylcellulose (HPC) content in WMGs. Good correlation between one in vitro dissolution parameter (mean dissolution time, MDT) and two in vivo parameters (AUC(12) and MRT) suggested that it would be possible to design WMGs with a desired in vivo performance by controlling HPC content.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 20 条
[1]   ABSORPTION, GASTROINTESTINAL TRANSIT, AND TABLET EROSION OF FELODIPINE EXTENDED-RELEASE (ER) TABLETS [J].
ABRAHAMSSON, B ;
ALPSTEN, M ;
HUGOSSON, M ;
JONSSON, UE ;
SUNDGREN, M ;
SVENHEDEN, A ;
TOLLI, J .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :709-714
[2]   EVALUATION OF THE CORRELATION BETWEEN INVIVO AND INVITRO RELEASE OF PHENYLPROPANOLAMINE HCL FROM CONTROLLED-RELEASE TABLETS [J].
AOKI, S ;
UESUGI, K ;
TATSUISHI, K ;
OZAWA, H ;
KAYANO, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 85 (1-3) :65-73
[3]   CONTROLLED-RELEASE MULTIPLE-UNITS AND SINGLE-UNIT DOSES - LITERATURE-REVIEW [J].
BECHGAARD, H ;
NIELSEN, GH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1978, 4 (01) :53-67
[4]   TRANSIT OF PHARMACEUTICAL DOSAGE FORMS THROUGH THE SMALL-INTESTINE [J].
DAVIS, SS ;
HARDY, JG ;
FARA, JW .
GUT, 1986, 27 (08) :886-892
[5]   THE GASTROINTESTINAL TRANSIT OF A CONTROLLED RELEASE FORMULATION OF INDOMETHACIN [J].
DAVIS, SS ;
KHOSLA, R ;
WILSON, CG ;
WASHINGTON, N ;
LESLIE, ST ;
MALKOWSKA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 60 (03) :191-196
[6]   COMPARISON OF CANINE AND HUMAN GASTROINTESTINAL PHYSIOLOGY [J].
DRESSMAN, JB .
PHARMACEUTICAL RESEARCH, 1986, 3 (03) :123-131
[7]   MEASUREMENT OF GASTROINTESTINAL PH PROFILES IN NORMAL AMBULANT HUMAN-SUBJECTS [J].
EVANS, DF ;
PYE, G ;
BRAMLEY, R ;
CLARK, AG ;
DYSON, TJ ;
HARDCASTLE, JD .
GUT, 1988, 29 (08) :1035-1041
[8]   ESTIMATION OF AGITATION INTENSITY IN THE GI TRACT IN HUMANS AND DOGS BASED ON IN-VITRO IN-VIVO CORRELATION [J].
KATORI, N ;
AOYAGI, N ;
TERAO, T .
PHARMACEUTICAL RESEARCH, 1995, 12 (02) :237-243
[9]   Effect of destruction force on drug release from multiple unit controlled release dosage forms in humans [J].
Katori, N ;
Ma, WS ;
Aoyagi, N ;
Kojima, S .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1541-1546
[10]   THE EFFECT OF FOOD ON THE GASTROINTESTINAL TRANSIT AND SYSTEMIC ABSORPTION OF NAPROXEN FROM A NOVEL SUSTAINED-RELEASE FORMULATION [J].
KENYON, CJ ;
HOOPER, G ;
TIERNEY, D ;
BUTLER, J ;
DEVANE, J ;
WILDING, IR .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (01) :31-36